Skip to main content
INNV
NASDAQ Industrial Applications And Services

InnovAge Appoints Jennifer Browne as President & COO to Drive Operational Improvement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.56
Mkt Cap
$1.025B
52W Low
$3.13
52W High
$10.69
52W Position info
142% above low
Off High info
29% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

INNV has more than doubled off its 52-week low of $3.13.

Summary

InnovAge appointed Jennifer Browne as President and COO, a key hire with a strong background in value-based care and operational improvement, signaling a strategic focus on strengthening company performance.


Key Events · Executive and Board Changes · INNV

  • New President & COO Appointed

    Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026.

  • Extensive Healthcare Experience

    Ms. Browne previously served as COO at Strive Health and SVP of Value & Population Health at Optum, bringing deep experience in value-based care, operational leadership, and compliance.

  • Strategic Focus on Performance

    Her role will focus on driving consistent execution, enhancing participant experience, and advancing performance across operational and compliance metrics, directly addressing areas of recent company challenge.

  • Comprehensive Compensation Package

    Compensation includes an annual base salary of $500,000, a $200,000 sign-on bonus, a target annual cash bonus of 75% of base salary, and annual restricted stock unit grants with a target value of $500,000, plus 1,260,000 Class B Units in TCO Group Holdings with a hurdle amount of $7.14.


Analysis · INNV · Industrial Applications And Services

InnovAge has appointed Jennifer Browne as its new President and Chief Operating Officer. This is a significant C-suite hire, particularly given the company's recent report of increased net losses due to litigation expenses. Ms. Browne's background in value-based kidney care, operational leadership, and compliance is directly aligned with InnovAge's stated focus on disciplined execution, regulatory excellence, and sustainable growth. Her appointment signals a strategic move to strengthen core operations and enhance performance.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INNV was trading at $7.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $3.13 to $10.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INNV - Latest Insights

INNV
Nov 03, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Nov 03, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Sep 23, 2026, 2:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.47 info
Change: -$0.180 (-2%) info
Market Cap: $1.292B info
INNV
Sep 22, 2026, 5:19 PM EDT
Filing Type: 424B7
Importance Score:
7
Price at Filing: $9.51
Real-time Price: $9.47 info
Change: -$0.040 (-0.42%) info
Market Cap: $1.292B info